SO, D., SD, P., LV, U., LF, A. S., O, G., A, R., . . . DM, K. (2026). Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02865-4
Chicago Style (17th ed.) CitationSO, Devenish, et al. "Next-generation Chemogenetic Inhibition Using a Brain-permeant Non-prescription Agent." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02865-4.
MLA (9th ed.) CitationSO, Devenish, et al. "Next-generation Chemogenetic Inhibition Using a Brain-permeant Non-prescription Agent." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02865-4.
Warning: These citations may not always be 100% accurate.